Connection
Gareth Morgan to Treatment Outcome
This is a "connection" page, showing publications Gareth Morgan has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.305 |
|
|
|
-
Vargas-Acevedo C, Zablah JE, Mejía E, Soszyn N, Kay J, Morgan GJ. Characterizing the Acute Changes in Pulmonary Capillary Wedge Pressure Associated With Transcatheter Pulmonary Valve Replacement. Catheter Cardiovasc Interv. 2025 Oct; 106(4):2724-2733.
Score: 0.086
-
Soszyn N, Minocha PK, Frank B, Mejia E, Zablah JE, Morgan GJ. Impact of echocardiographic and computed-tomography assessment of Sano shunt stenosis on need for percutaneous intervention. Int J Cardiovasc Imaging. 2025 May; 41(5):859-868.
Score: 0.083
-
Mejia E, Leahy RA, Zablah JE, Morgan GJ. Using a customized telescoped stent complex in the percutaneous treatment of a residual superior sinus venosus defect. Catheter Cardiovasc Interv. 2024 11; 104(5):999-1002.
Score: 0.080
-
Zablah JE, Than J, Browne LP, Rodriguez S, Morgan GJ. Patient Screening for Self-Expanding Percutaneous Pulmonary Valves Using Virtual Reality. J Am Heart Assoc. 2024 Mar 19; 13(6):e033239.
Score: 0.078
-
Sola M, Kay J, Messenger J, Zablah J, Soszyn N, Morgan G. Transcatheter closure of a large coronary cameral fistula presenting as a calcified cystic right atrial mass. Catheter Cardiovasc Interv. 2024 03; 103(4):607-611.
Score: 0.077
-
Gonzalez de Alba C, Zablah JE, Burkett D, Jone PN, Rodriguez SA, Morgan GJ. Use of Three-Dimensional Intracardiac Echocardiography Catheter in the Evaluation of Prosthetic Pulmonary Valves after Transcatheter Replacement. J Am Soc Echocardiogr. 2024 Feb; 37(2):226-236.
Score: 0.075
-
Minocha PK, Caputo M, Ramroop R, Morgan GJ. Use of the Occlutech pmVSD Device for Hybrid Closure of a Large Mid-Muscular Ventricular Septal Defect in a Small Infant Born With Hypoplastic Aortic Arch. World J Pediatr Congenit Heart Surg. 2024 01; 15(1):109-111.
Score: 0.075
-
Mejia E, McLennan D, Zablah J, Soszyn N, Shibbani K, Morgan GJ. Establishing Carotid Seldinger as Routine Access in Infants; Planning, Performance, and Follow-Up Protocols. Pediatr Cardiol. 2023 Dec; 44(8):1815-1820.
Score: 0.075
-
Morgan GJ, Zablah J. A new FDA approved stent for congenital heart disease: First-in-man experiences with G-ARMORTM. Catheter Cardiovasc Interv. 2022 12; 100(7):1261-1266.
Score: 0.071
-
Zablah JE, Døhlen G, Ystgaard MB, Morgan GJ. Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation. Catheter Cardiovasc Interv. 2022 10; 100(4):606-611.
Score: 0.070
-
Zablah JE, O'Callaghan B, Shorofsky M, Ivy D, Morgan GJ. Technical Feasibility on the Use of Optical Coherence Tomography in the Evaluation of Pediatric Pulmonary Venous Stenosis. Pediatr Cardiol. 2022 Jun; 43(5):1054-1063.
Score: 0.067
-
Zablah JE, Rodriguez SA, Leahy R, Morgan GJ. Novel Minimal Radiation Approach for Percutaneous Pulmonary Valve Implantation. Pediatr Cardiol. 2021 Apr; 42(4):926-933.
Score: 0.063
-
Morgan GJ, Rodriguez SA, Leahy R, Zablah JE. Coronary compression testing by balloon interrogation during pulmonary valve implantation: room for doubt? Cardiol Young. 2021 Sep; 31(9):1419-1425.
Score: 0.063
-
Zablah JE, Morgan GJ. Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful intervention. Eur Heart J Cardiovasc Imaging. 2020 10 01; 21(10):1151.
Score: 0.061
-
Shahanavaz S, Aldoss O, Carr K, Gordon B, Seckeler MD, Hiremath G, Seaman C, Zablah J, Morgan G. Acute and medium term results of balloon expandable stent placement in the transverse arch-a multicenter pediatric interventional cardiology early career society study. Catheter Cardiovasc Interv. 2020 11; 96(6):1277-1286.
Score: 0.061
-
Morgan GJ, Narayan SA, Goreczny S, Chubb H, Krasemann T, Rosenthal E, Qureshi SA. A low threshold for neonatal intervention yields a high rate of biventricular outcomes in pulmonary atresia with intact ventricular septum. Cardiol Young. 2020 May; 30(5):649-655.
Score: 0.059
-
Morgan GJ, Sivakumar K, Promphan W, Goreczny S, Prachasilchai P, Qureshi S. Early clinical experience with the straight design of Venus P-valve? in dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2020 11; 96(6):E653-E659.
Score: 0.059
-
Nishimura KK, Barlogie B, van Rhee F, Zangari M, Walker BA, Rosenthal A, Schinke C, Thanendrarajan S, Davies FE, Hoering A, Morgan GJ. Long-term outcomes after autologous stem cell transplantation for multiple myeloma. Blood Adv. 2020 Jan 28; 4(2):422-431.
Score: 0.058
-
McLennan D, Ivy D, Morgan GJ. Transvenous implantation of the Occlutech Atrial Flow Regulator: Preliminary results from swine models. Congenit Heart Dis. 2019 Sep; 14(5):819-831.
Score: 0.056
-
Morgan G, Prachasilchai P, Promphan W, Rosenthal E, Sivakumar K, Kappanayil M, Sakidjan I, Walsh KP, Kenny D, Thomson J, Koneti NR, Awasthy N, Thanopoulos B, Roymanee S, Qureshi S. Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experience. EuroIntervention. 2019 Jan 20; 14(13):1363-1370.
Score: 0.054
-
Zablah JE, Fry R, Ross M, Wilson N, Morgan G. Using in vitro model to assess stent-stent interaction in patients with coronary artery compression. J Interv Cardiol. 2018 Dec; 31(6):870-877.
Score: 0.053
-
Morgan GJ, Sadeghi S, Salem MM, Wilson N, Kay J, Rothman A, Galindo A, Martin MH, Gray R, Ross M, Aboulhosn JA, Levi DS. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019 02 01; 93(2):324-329.
Score: 0.053
-
Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan GJ. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018 08 09; 132(6):587-597.
Score: 0.052
-
Morgan GJ, Pushparajah K, Narayan S, Rosenthal E. Large Calibre Self-Expanding Stents for Pulmonary Stenosis After the Arterial Switch, a Low-Risk Solution to a Low-Flow Situation. Pediatr Cardiol. 2018 Apr; 39(4):824-828.
Score: 0.051
-
Morgan GJ, Ciuffreda M, Spadoni I, DeGiovanni J. Optimus covered stent: Advanced covered stent technology for complex congenital heart disease. Congenit Heart Dis. 2018 May; 13(3):458-462.
Score: 0.051
-
Morgan GJ, Kenny D, Duke C, Walsh KP, Qureshi SA. Initial assessment of a novel delivery system (NuDEL? ®) for the covered Cheatham-Platinum stent. Cardiol Young. 2017 Oct; 27(8):1465-1469.
Score: 0.050
-
Goreczny S, Qureshi SA, Rosenthal E, Krasemann T, Nassar MS, Anderson DR, Morgan GJ. Comparison of self-expandable and balloon-expanding stents for hybrid ductal stenting in hypoplastic left heart complex. Cardiol Young. 2017 Jul; 27(5):837-845.
Score: 0.049
-
Carmo Mendes I, Heard H, Peacock K, Krasemann T, Morgan GJ. Echocardiographic Versus Angiographic Assessment of Patent Arterial Duct in Percutaneous Closure: Towards X-ray Free Duct Occlusion? Pediatr Cardiol. 2017 Feb; 38(2):302-307.
Score: 0.047
-
Goreczny S, Bedair R, Bilska K, Morgan G. Retrieving a large embolised atrial septal occluder - hooked? and landed. Kardiol Pol. 2017; 75(3):277.
Score: 0.047
-
Husain J, Praichasilchai P, Gilbert Y, Qureshi SA, Morgan GJ. Early European experience with the Venus P-valve®: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016 Aug 05; 12(5):e643-51.
Score: 0.046
-
Mainzer G, Rosenthal E, Austin C, Morgan G. Hybrid Approach for Recanalization and Stenting of Acquired Pulmonary Vein Occlusion. Pediatr Cardiol. 2016 Jun; 37(5):983-5.
Score: 0.045
-
Goreczny S, Qureshi S, Rosenthal E, Krasemann T, Bedair R, Salih C, Austin C, Anderson D, Morgan GJ. Self-expanding stent implantation in arterial duct during hybrid palliation of hypoplastic left heart syndrome: midterm experience with a specially designed stent. EuroIntervention. 2015 Mar; 10(11):1318-25.
Score: 0.041
-
Brioli A, Giles H, Pawlyn C, Campbell JP, Kaiser MF, Melchor L, Jackson GH, Gregory WM, Owen RG, Child JA, Davies FE, Cavo M, Drayson MT, Morgan GJ. Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome. Blood. 2014 May 29; 123(22):3414-9.
Score: 0.039
-
Shepherd E, Connolly GM, Morgan G. Using the Valeo dilatable stent in coarctation stenting for small children: expanding the inclusion criteria for coarctation stenting? BMJ Case Rep. 2013 Dec 11; 2013.
Score: 0.038
-
Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):581-6.
Score: 0.038
-
Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Cook G, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA. Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment. Clin Cancer Res. 2013 Nov 01; 19(21):6030-8.
Score: 0.037
-
Morgan GJ, Lee KJ, Chaturvedi R, Bradley TJ, Mertens L, Benson L. Systemic blood pressure after stent management for arch coarctation implications for clinical care. JACC Cardiovasc Interv. 2013 Feb; 6(2):192-201.
Score: 0.036
-
Morgan GJ, Yim DL, Hayes AM, Martin RP, Hamilton MC, Stuart G. Imaging and percutaneous occlusion of a large aneurysm of the ductus arteriosus in an infant with Loeys-Dietz syndrome. Congenit Heart Dis. 2013 Nov-Dec; 8(6):E192-5.
Score: 0.036
-
Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ. Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension. Cardiol Young. 2013 Oct; 23(5):692-6.
Score: 0.035
-
Morgan G, Benson L, Geary D. Middle aortic syndrome with renal involvement: a staged strategy to manage systemic hypertension. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):E5-8.
Score: 0.033
-
Morgan GJ, Waragai T, Eastaugh L, Chaturvedi RC, Lee KJ, Benson L. The fellows stitch: large caliber venous hemostasis in pediatric practice. Catheter Cardiovasc Interv. 2012 Jul 01; 80(1):79-82.
Score: 0.033
-
Morgan GJ. Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma? Crit Rev Oncol Hematol. 2011 Feb; 77 Suppl 1:S24-30.
Score: 0.031
-
Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross F, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Child JA. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet. 2010 Dec 11; 376(9757):1989-99.
Score: 0.031
-
Morgan G, Lee KJ, Chaturvedi R, Benson L. A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):241-5.
Score: 0.030
-
Morgan GJ, Clarke K, Caldarone C, Benson LN. Radiolucent retractor for angiographic analysis during hybrid congenital cardiac procedures. J Thorac Cardiovasc Surg. 2010 Nov; 140(5):1195-6.
Score: 0.030
-
Morgan G, Caldarone C, Anderson R, Chaturvedi R. Anomalous origin of the left coronary artery from the right pulmonary artery presenting following relief of left heart obstruction: a distinct and predictable clinico-pathological syndrome. Congenit Heart Dis. 2010 May-Jun; 5(3):327-30.
Score: 0.030
-
Morgan G, Tometzki AJ, Martin RP. Transcatheter closure of long tubular patent arterial ducts: The Amplatzer Duct Occluder II-A new and valuable tool. Catheter Cardiovasc Interv. 2009 Mar 01; 73(4):576-80.
Score: 0.027
-
Davies FE, Wu P, Jenner M, Srikanth M, Saso R, Morgan GJ. The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone. Haematologica. 2007 Aug; 92(8):1149-50.
Score: 0.025
-
Luetkemeyer AF, Chew KW, Lacey S, Hughes MD, Harrison LJ, Daar ES, Eron J, Fletcher CV, Greninger AL, Hessinger D, Li JZ, Mailhot D, Wohl D, Chayakulkeeree M, Mendoza JLA, Elistratova P, Makinde O, Morgan G, Portsmouth S, Uehara T, Smith D, Currier JS. Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial. Clin Infect Dis. 2025 Jul 18; 80(6):1235-1244.
Score: 0.021
-
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N. Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis. Leuk Lymphoma. 2025 May; 66(5):942-951.
Score: 0.021
-
Rosenthal E, Qureshi SA, Sivakumar K, Jones M, Yong SF, Kabir S, Sagar P, Thejaswi P, Hascoet S, Batteux C, Boudjemline Y, Hijazi ZM, Aboulhosn JA, Levi DS, Salem MM, Francis E, Kempny A, Fraisse A, Bautista-Rodriguez C, Walsh K, Kenny D, Traynor B, Al Maskari SN, Bentham JR, Környei L, Sivaprakasam MC, Firouzi A, Khajali Z, Benson L, Osten M, Baruteau AE, Crystal MA, Forbes TJ, Georgiev S, Sievert H, Tin DN, Springmuller D, Subramanian A, Abdullah HAM, Bedair R, Chamié F, Celebi A, Damsky Barbosa J, De Meester P, Giugno L, Jalal Z, Karsenty C, Schleiger A, Fleming G, Jakob A, Karagoaz T, Mainzer G, Morgan GJ, Narin N, Shahanavaz S, Steinberg ZL, Aldoss O, Alizade E, Aregullin O, Bouvaist H, Fleck T, Godart F, Malekzadeh-Milani S, Motta P, Sanchez-Recalde A, Sandoval JP, Tan W, Thomson J, Tomé Teixeirense P, Zahn EM. Covered Stent Correction for Sinus Venosus Atrial Septal Defects, an Emerging Alternative to Surgical Repair: Results of an International Registry. Circulation. 2025 Mar 18; 151(11):744-756.
Score: 0.020
-
Dimas VV, Babaliaros V, Kim D, Lim DS, Morgan G, Jones TK, Armstrong AK, Berman D, Aboulhosn J, Mahadevan VS, Gillespie MJ, Balzer D, Zellers T, Yu X, Shirali G, Parthiban A, Leipsic J, Blanke P, Zahn E, Shahanavaz S. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2287-2297.
Score: 0.020
-
Qureshi AM, Sommer RJ, Morgan G, Paolillo JA, Gray RG, Love B, Goldstein BH, Sugeng L, Gillespie MJ. Long-Term Results of the Atrial Septal Defect Occluder ASSURED Trial for Combined Pivotal/Continued Access Cohorts. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2274-2283.
Score: 0.020
-
Kilgallon KB, Leroue M, Shankman S, Shea T, Buckvold S, Mitchell M, Morgan G, Zablah J, Maddux AB. Extubated, Rehabilitation-Focused Extracorporeal Membrane Oxygenation for Pediatric Coronavirus Disease 2019: A Case Series. ASAIO J. 2025 Apr 01; 71(4):e66-e71.
Score: 0.020
-
Minen F, Durward A, James P, Diamantopoulos A, Jogeesvaran H, Morgan GJ, Nyman A. Single-center review on safety of biodegradable airway stenting in pediatric population. Pediatr Pulmonol. 2023 Dec; 58(12):3437-3446.
Score: 0.019
-
Mejia E, Cummer E, Morgan GJ, Buckvold S, Mitchell M, Leahy RA, Zablah JE. Percutaneous VA-ECMO from Cannulation to Decannulation: Novel Use of a Vascular Closure Device in Pediatrics. Pediatr Cardiol. 2023 Oct; 44(7):1623-1628.
Score: 0.019
-
Shorofsky MJ, Morgan GJ, Mejia E, Rodriguez SA, Greene M, Sheaks P, Ivy D, Zablah JE. Management of Complex Pulmonary Vein Stenosis at Altitude Combining Comprehensive Percutaneous Interventional Treatment with Sirolimus, Pulmonary Hypertension Medications and Intraluminal Imaging with Optical Coherence Tomography. Pediatr Cardiol. 2023 Jun; 44(5):1125-1134.
Score: 0.018
-
Callahan R, McGovern E, Nageotte SJ, Ligon RA, Morgan GJ, Johnston TA, Marshall AC. Pediatric and Congenital Interventional Cardiology Training: The North American Landscape in 2022. JACC Cardiovasc Interv. 2022 07 25; 15(14):1480-1485.
Score: 0.017
-
de Tute RM, Pawlyn C, Cairns DA, Davies FE, Menzies T, Rawstron A, Jones JR, Hockaday A, Henderson R, Cook G, Drayson MT, Jenner MW, Kaiser MF, Gregory WM, Morgan GJ, Jackson GH, Owen RG. Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk. J Clin Oncol. 2022 09 01; 40(25):2889-2900.
Score: 0.017
-
Venardos N, Mangham C, Morgan GJ, Zablah JE, Jaggers J, Stone ML. Two-Stage Biventricular Repair of Complex Aortic Atresia. Ann Thorac Surg. 2023 04; 115(4):e101-e103.
Score: 0.017
-
Frank BS, Khailova L, Silveira L, Mitchell MB, Morgan GJ, DiMaria MV, Davidson JA. Increased Circulating Endothelin 1 Is Associated With Postoperative Hypoxemia in Infants With Single-Ventricle Heart Disease Undergoing Superior Cavopulmonary Anastomosis. J Am Heart Assoc. 2022 03 15; 11(6):e024007.
Score: 0.017
-
Wilkinson D, Lin Y, Everett M, Auerbach S, Morgan G, Mitchell MB. Coronary Artery Reimplantation and Berlin Heart EXCOR Rescue for Left Coronary Artery Atresia With Severe Ischemic Cardiomyopathy. World J Pediatr Congenit Heart Surg. 2021 Nov; 12(6):793-795.
Score: 0.016
-
Davies F, Rifkin R, Costello C, Morgan G, Usmani S, Abonour R, Palumbo A, Romanus D, Hajek R, Terpos E, Cherepanov D, Stull DM, Huang H, Leleu X, Berdeja J, Lee HC, Weisel K, Thompson M, Boccadoro M, Zonder J, Cook G, Puig N, Vela-Ojeda J, Farrelly E, Raju A, Blazer M, Chari A. Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US. Ann Hematol. 2021 Sep; 100(9):2325-2337.
Score: 0.016
-
Bird S, Cairns D, Menzies T, Boyd K, Davies F, Cook G, Drayson M, Gregory W, Jenner M, Jones J, Kaiser M, Owen R, Jackson G, Morgan G, Pawlyn C. Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial. Clin Lymphoma Myeloma Leuk. 2021 10; 21(10):667-675.
Score: 0.016
-
Brown S, Pawlyn C, Tillotson AL, Sherratt D, Flanagan L, Low E, Morgan GJ, Williams C, Kaiser M, Davies FE, Jenner MW. Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial. Clin Lymphoma Myeloma Leuk. 2021 03; 21(3):154-161.e3.
Score: 0.015
-
Frank BS, Khailova L, Silveira L, Mitchell MB, Morgan GJ, Hsieh EWY, DiMaria MV, Twite M, Klawitter J, Davidson JA. Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls. Transl Res. 2021 03; 229:24-37.
Score: 0.015
-
Dimopoulos MA, ?picka I, Quach H, Oriol A, Hájek R, Garg M, Beksac M, Bringhen S, Katodritou E, Chng WJ, Leleu X, Iida S, Mateos MV, Morgan G, Vorog A, Labotka R, Wang B, Palumbo A, Lonial S. Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial. J Clin Oncol. 2020 12 01; 38(34):4030-4041.
Score: 0.015
-
Jackson GH, Pawlyn C, Cairns DA, Striha A, Collett C, Waterhouse A, Jones JR, Wilson J, Taylor C, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Jenner MW, Cook G, Russell NH, Drayson MT, Kaiser MF, Owen RG, Gregory WM, Davies FE, Morgan GJ. Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial. Br J Haematol. 2021 03; 192(5):853-868.
Score: 0.015
-
Griffiths BT, James P, Morgan G, Diamantopoulos A, Durward A, Nyman A. Biodegradable Stents for the Relief of Vascular Bronchial Compression in Children With Left Atrial Enlargement. J Bronchology Interv Pulmonol. 2020 Jul; 27(3):200-204.
Score: 0.015
-
Ehrmann DE, Leopold DK, Phillips R, Shahi N, Campbell K, Ross M, Zablah JE, Moulton SL, Morgan G, Kim JS. The Compensatory Reserve Index Responds to Acute Hemodynamic Changes in Patients with Congenital Heart Disease: A Proof of Concept Study. Pediatr Cardiol. 2020 Aug; 41(6):1190-1198.
Score: 0.015
-
Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, Gillespie MJ. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020 06 01; 95(7):1285-1295.
Score: 0.015
-
Schäfer M, Barker AJ, Morgan GJ, Jaggers J, Stone ML, Browne LP, Ivy DD, Mitchell MB. Increased systolic vorticity in the left ventricular outflow tract is associated with abnormal aortic flow formations in Tetralogy of Fallot. Int J Cardiovasc Imaging. 2020 Apr; 36(4):691-700.
Score: 0.015
-
Frank BS, Schäfer M, Douwes JM, Ivy DD, Abman SH, Davidson JA, Burzlaff S, Mitchell MB, Morgan GJ, Browne LP, Barker AJ, Truong U, von Alvensleben JC. Novel measures of left ventricular electromechanical discoordination predict clinical outcomes in children with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2020 02 01; 318(2):H401-H412.
Score: 0.014
-
Schäfer M, Browne LP, Jaggers J, Barker AJ, Morgan GJ, Ivy DD, Mitchell MB. Abnormal left ventricular flow organization following repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2020 Oct; 160(4):1008-1015.
Score: 0.014
-
Hiremath G, Morgan G, Kenny D, Batlivala SP, Bartakian S. Balloon expandable covered stents as primary therapy for hemodynamically stable traumatic aortic injuries in children. Catheter Cardiovasc Interv. 2020 02 15; 95(3):477-483.
Score: 0.014
-
Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Waterhouse A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Wilson JN, Jenner MW, Cook G, Kaiser MF, Drayson MT, Owen RG, Russell NH, Gregory WM, Morgan GJ. Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Lancet Haematol. 2019 Dec; 6(12):e616-e629.
Score: 0.014
-
Kenny D, Morgan GJ, Murphy M, AlAlwi K, Giugno L, Zablah J, Carminati M, Walsh K. Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2019 Sep 01; 94(3):409-413.
Score: 0.014
-
Jones JR, Weinhold N, Ashby C, Walker BA, Wardell C, Pawlyn C, Rasche L, Melchor L, Cairns DA, Gregory WM, Johnson D, Begum DB, Ellis S, Sherborne AL, Cook G, Kaiser MF, Drayson MT, Owen RG, Jackson GH, Davies FE, Greaves M, Morgan GJ. Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients. Haematologica. 2019 07; 104(7):1440-1450.
Score: 0.014
-
Cook G, Royle KL, Pawlyn C, Hockaday A, Shah V, Kaiser MF, Brown SR, Gregory WM, Child JA, Davies FE, Morgan GJ, Cairns DA, Jackson GH. A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study. Lancet Haematol. 2019 Mar; 6(3):e154-e166.
Score: 0.014
-
Jone PN, Haak A, Petri N, Ross M, Morgan G, Wiktor DM, Gill E, Quaife RA, Messenger JC, Salcedo EE, Carroll JD. Echocardiography-Fluoroscopy Fusion Imaging for Guidance of Congenital and Structural Heart Disease Interventions. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1279-1282.
Score: 0.014
-
Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Hockaday A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Jenner MW, Cook G, Russell NH, Kaiser MF, Drayson MT, Owen RG, Gregory WM, Morgan GJ. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2019 01; 20(1):57-73.
Score: 0.013
-
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2019 01 19; 393(10168):253-264.
Score: 0.013
-
Schäfer M, Browne LP, Morgan GJ, Barker AJ, Fonseca B, Ivy DD, Mitchell MB. Reduced proximal aortic compliance and elevated wall shear stress after early repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2018 12; 156(6):2239-2249.
Score: 0.013
-
Mainzer G, Goreczny S, Morgan GJ, Qureshi S, Krasemann T, Dryzek P, Moll JA, Moszura T, Rosenthal E. Stenting of the inter-atrial septum in infants and small children: Indications, techniques and outcomes. Catheter Cardiovasc Interv. 2018 06; 91(7):1294-1300.
Score: 0.013
-
Campbell JP, Heaney JLJ, Pandya S, Afzal Z, Kaiser M, Owen R, Child JA, Cairns DA, Gregory W, Morgan GJ, Jackson GH, Bunce CM, Drayson MT. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study. Lancet Haematol. 2017 Dec; 4(12):e584-e594.
Score: 0.013
-
Kang SL, Jivanji S, Mehta C, Tometzki AJ, Derrick G, Yates R, Khambadkone S, de Giovanni J, Stumper O, Dhillon R, Bhole V, Slavik Z, Rigby M, Noonan P, Smith B, Knight B, Richens T, Wilson N, Walsh K, James A, Thomson J, Bentham J, Hayes N, Nazir S, Adwani S, Shauq A, Ramaraj R, Duke C, Taliotis D, Kudumula V, Yong SF, Morgan G, Rosenthal E, Krasemann T, Qureshi S, Crossland D, Hermuzi T, Martin RP. Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: A national study from United Kingdom and Ireland. Catheter Cardiovasc Interv. 2017 Dec 01; 90(7):1135-1144.
Score: 0.012
-
Wadia SK, Accavitti MJ, Morgan GJ, Kenny D, Hijazi ZM, Jones TK, Cabalka AK, McElhinney DB, Kavinsky CJ. Transcatheter interventions in adults with congenital heart disease: Surveys from the Society for Cardiovascular Angiography and Interventions to identify current patterns of care and perception on training requirements. Catheter Cardiovasc Interv. 2017 Sep 01; 90(3):418-424.
Score: 0.012
-
Goreczny S, Morgan GJ, Dryzek P, Moll JA, Moszura T. Initial experience with live three-dimensional image overlay for ductal stenting in hypoplastic left heart syndrome. EuroIntervention. 2016 Dec 20; 12(12):1527-1533.
Score: 0.012
-
Sandoval JP, Chaturvedi RR, Benson L, Morgan G, Van Arsdell G, Honjo O, Caldarone C, Lee KJ. Right Ventricular Outflow Tract Stenting in Tetralogy of Fallot Infants With Risk Factors for Early Primary Repair. Circ Cardiovasc Interv. 2016 12; 9(12).
Score: 0.012
-
Wu SP, Pfeiffer RM, Ahn IE, Mailankody S, Sonneveld P, van Duin M, Munshi NC, Walker BA, Morgan G, Landgren O. Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients. Clin Cancer Res. 2016 Aug 15; 22(16):4039-44.
Score: 0.011
-
Chen CK, Cifra B, Morgan GJ, Sarkola T, Slorach C, Wei H, Bradley TJ, Manlhiot C, McCrindle BW, Redington AN, Benson LN, Mertens L. Left Ventricular Myocardial and Hemodynamic Response to Exercise in Young Patients after Endovascular Stenting for Aortic Coarctation. J Am Soc Echocardiogr. 2016 Mar; 29(3):237-46.
Score: 0.011
-
de Tute RM, Rawstron AC, Gregory WM, Child JA, Davies FE, Bell SE, Cook G, Szubert AJ, Drayson MT, Jackson GH, Morgan GJ, Owen RG. Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen. Haematologica. 2016 Feb; 101(2):e69-71.
Score: 0.011
-
Murphy MO, Bellsham-Revell H, Morgan GJ, Krasemann T, Rosenthal E, Qureshi SA, Salih C, Austin CB, Anderson DR. Hybrid Procedure for Neonates With Hypoplastic Left Heart Syndrome at High-Risk for Norwood: Midterm Outcomes. Ann Thorac Surg. 2015 Dec; 100(6):2286-90; discussion 2291-2.
Score: 0.011
-
Goreczny S, Morgan GJ, Dryzek P. Live 3D image overlay for arterial duct closure with Amplatzer Duct Occluder II additional size. Cardiol Young. 2016 Mar; 26(3):605-8.
Score: 0.011
-
Kang SL, Tometzki A, Caputo M, Morgan G, Parry A, Martin R. Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv. 2015 May; 85(6):998-1005.
Score: 0.010
-
Ludwig H, Sonneveld P, Davies F, Bladé J, Boccadoro M, Cavo M, Morgan G, de la Rubia J, Delforge M, Dimopoulos M, Einsele H, Facon T, Goldschmidt H, Moreau P, Nahi H, Plesner T, San-Miguel J, Hajek R, Sondergeld P, Palumbo A. European perspective on multiple myeloma treatment strategies in 2014. Oncologist. 2014 Aug; 19(8):829-44.
Score: 0.010
-
Kang SL, Morgan G, Forsey J, Tometzki A, Martin R. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1102-8.
Score: 0.010
-
Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O. Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):467-73.
Score: 0.009
-
Kenny D, Morgan GJ, Bentham JR, Wilson N, Martin R, Tometzki A, Oslizlok P, Walsh KP. Early clinical experience with a modified Amplatzer ductal occluder for transcatheter arterial duct occlusion in infants and small children. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):534-40.
Score: 0.009
-
Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. Hematology. 2011 Jul; 16(4):213-20.
Score: 0.008
-
Bird JM, Owen RG, D'Sa S, Snowden JA, Pratt G, Ashcroft J, Yong K, Cook G, Feyler S, Davies F, Morgan G, Cavenagh J, Low E, Behrens J. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol. 2011 Jul; 154(1):32-75.
Score: 0.008
-
Waragai T, Morgan G, Ralston T, Chaturvedi R, Lee KJ, Benson L. Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children. Catheter Cardiovasc Interv. 2011 Aug 01; 78(2):262-6.
Score: 0.008
-
Cook G, Liakopoulou E, Pearce R, Cavet J, Morgan GJ, Kirkland K, Lee J, Davies FE, Hall R, Rahemtulla A, Russell N, Marks DI. Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1638-45.
Score: 0.008
-
Gedicke M, Morgan G, Parry A, Martin R, Tulloh R. Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations. Heart Vessels. 2010 Sep; 25(5):405-9.
Score: 0.008
-
Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, Martin R. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):615-23.
Score: 0.007
-
Chakrabarti S, Kenny D, Morgan G, Curtis SL, Hamilton MC, Wilde P, Tometzki AJ, Turner MS, Martin RP. Balloon expandable stent implantation for native and recurrent coarctation of the aorta--prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010 Aug; 96(15):1212-6.
Score: 0.007
-
Kenny D, Morgan G, Bajwa A, Farrow C, Parry A, Caputo M, Tometzki A, Martin R. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Catheter Cardiovasc Interv. 2009 Mar 01; 73(4):568-75.
Score: 0.007
-
Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kröger N, Schattenberg A, Schönland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica. 2007 Nov; 92(11):1513-8.
Score: 0.006
-
Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004 Dec 15; 104(13):3872-7.
Score: 0.005
-
Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood. 2002 Feb 15; 99(4):1136-43.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|